Transcreener^® ADP² FP Assay uses a highly sensitive antibody against ADP and a far-red tracer to produce an excellent signal at less than 10% ATP consumption for a broad range of initial ATP concentrations (0.1-1,000 µM). Both reagents and signal are stable at room temperature for over 24 hours providing outstanding flexibility for automated high-volume screening programs. Used in over millions of wells by pharma since 2006, Transcreener is the most extensively validated ADP detection method available backed by the best technical support in the industry.